HOOPER, LUNDY & BOOKMAN, P.C. lobbying for BRAINFUTURES

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 19, 2025

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Lobbyists on this filing 1

LISA LAYMAN New on this filing

Previously held: SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001- 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 5

HR 3944
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
HR 2623
Innovative Therapies Centers of Excellence Act of 2025
S 331
HALT Fentanyl Act
HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Lobbying activity 4

Veterans

H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R.2623 - Innovative Therapies Centers of Excellence Act of 2025.

Health Issues

Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.

Medical/Disease Research/Clinical Labs

Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.

Budget/Appropriations

H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research, H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, support for psychedelic therapies for treatment of mental health and substance use disorders.